BOTOTLSJU
VIR icon

Board of Trustees of The Leland Stanford Junior University’s Vir Biotechnology VIR Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-38,905
Closed -$1.33M – 25
2020
Q1 		$1.33M Hold
38,905
– – 0.27% 14
2019
Q4 		$490K Buy
+38,905
New +$521K 0.06% 21

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.44B AUM 23.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's VIR Position: Q2 2020 in Review

Board of Trustees of The Leland Stanford Junior University sold out of Vir Biotechnology (VIR) in Q2 2020, closing a stake of 38,905 shares — an estimated $1.33M sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in VIR in Q4 2019 and held it in 2 quarters. The position peaked at $1.33M in Q1 2020. 112 funds tracked by Wall St. Rank hold VIR as of Q2 2020.

  • Board of Trustees of The Leland Stanford Junior University reported no remaining Vir Biotechnology position as of Q2 2020 after selling out during the quarter.
  • Board of Trustees of The Leland Stanford Junior University sold 38,905 Vir Biotechnology shares in Q2 2020, an estimated $1.33M.
  • Board of Trustees of The Leland Stanford Junior University first reported a position in Vir Biotechnology in Q4 2019 and held it in 2 quarters.
  • Board of Trustees of The Leland Stanford Junior University's Vir Biotechnology position peaked at $1.33M in Q1 2020.
  • 112 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2020.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q2 2020, filed 12 Aug 2020.